+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genome Engineering Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • October 2021
  • Region: Global
  • TechNavio
  • ID: 5514025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the genome engineering market and it is poised to grow by $3.89 bn during 2021-2025, progressing at a CAGR of 14.45% during the forecast period. Our report on the genome engineering market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing applications of genome engineering in therapeutics and increase in human genomics research. In addition, increasing applications of genome engineering in therapeutics is anticipated to boost the growth of the market as well.

The genome engineering market analysis includes the technology segment and geographic landscape.

The publisher's genome engineering market is segmented as below:


By Technology


  • CRISPR
  • TALEN
  • ZFN
  • Others

By Geographical Landscape


  • North America
  • Europe
  • Asia
  • ROW

This study identifies the potential opportunities in orphan diseases and oncology as one of the prime reasons driving the genome engineering market growth during the next few years.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on genome engineering market covers the following areas:
  • Genome engineering market sizing
  • Genome engineering market forecast
  • Genome engineering market industry analysis

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Technology
  • Market segments
  • Comparison by Technology
  • CRISPR - Market size and forecast 2020-2025
  • TALEN - Market size and forecast 2020-2025
  • ZFN - Market size and forecast 2020-2025
  • Others - Market size and forecast 2020-2025
  • Market opportunity by Technology

Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • CRISPR Therapeutics AG
  • Danaher Corp.
  • GenScript Biotech Corp.
  • Hera Biolabs Inc.
  • Illumina Inc.
  • Intellia Therapeutics Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Sangamo Therapeutics Inc.
  • Thermo Fisher Scientific Inc.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Technology - Market share 2020-2025 (%)
22: Comparison by Technology
23: CRISPR - Market size and forecast 2020-2025 ($ million)
24: CRISPR - Year-over-year growth 2020-2025 (%)
25: TALEN - Market size and forecast 2020-2025 ($ million)
26: TALEN - Year-over-year growth 2020-2025 (%)
27: ZFN - Market size and forecast 2020-2025 ($ million)
28: ZFN - Year-over-year growth 2020-2025 (%)
29: Others - Market size and forecast 2020-2025 ($ million)
30: Others - Year-over-year growth 2020-2025 (%)
31: Market opportunity by Technology
32: Customer landscape
33: Market share By Geographical Landscape 2020-2025 (%)
34: Geographic comparison
35: North America - Market size and forecast 2020-2025 ($ million)
36: North America - Year-over-year growth 2020-2025 (%)
37: Europe - Market size and forecast 2020-2025 ($ million)
38: Europe - Year-over-year growth 2020-2025 (%)
39: Asia - Market size and forecast 2020-2025 ($ million)
40: Asia - Year-over-year growth 2020-2025 (%)
41: ROW - Market size and forecast 2020-2025 ($ million)
42: ROW - Year-over-year growth 2020-2025 (%)
43: Key leading countries
44: Market opportunity By Geographical Landscape ($ million)
45: Impact of drivers and challenges
46: Vendor landscape
47: Landscape disruption
48: Industry risks
49: Vendors covered
50: Market positioning of vendors
51: CRISPR Therapeutics AG - Overview
52: CRISPR Therapeutics AG - Business segments
53: CRISPR Therapeutics AG - Key offerings
54: CRISPR Therapeutics AG - Key customers
55: CRISPR Therapeutics AG - Segment focus
56: Danaher Corp. - Overview
57: Danaher Corp. - Business segments
58: Danaher Corp. - Key offerings
59: Danaher Corp. - Key customers
60: Danaher Corp. - Segment focus
61: GenScript Biotech Corp. - Overview
62: GenScript Biotech Corp. - Business segments
63: GenScript Biotech Corp. - Key offerings
64: GenScript Biotech Corp. - Key customers
65: GenScript Biotech Corp. - Segment focus
66: Hera Biolabs Inc. - Overview
67: Hera Biolabs Inc. - Product and service
68: Hera Biolabs Inc. - Key offerings
69: Hera Biolabs Inc. - Key customers
70: Hera Biolabs Inc. - Segment focus
71: Illumina Inc. - Overview
72: Illumina Inc. - Product and service
73: Illumina Inc. - Key offerings
74: Illumina Inc. - Key customers
75: Illumina Inc. - Segment focus
76: Intellia Therapeutics Inc. - Overview
77: Intellia Therapeutics Inc. - Business segments
78: Intellia Therapeutics Inc. - Key offerings
79: Intellia Therapeutics Inc. - Key customers
80: Intellia Therapeutics Inc. - Segment focus
81: Merck KGaA - Overview
82: Merck KGaA - Business segments
83: Merck KGaA - Key offerings
84: Merck KGaA - Key customers
85: Merck KGaA - Segment focus
86: PerkinElmer Inc. - Overview
87: PerkinElmer Inc. - Business segments
88: PerkinElmer Inc. - Key offerings
89: PerkinElmer Inc. - Key customers
90: PerkinElmer Inc. - Segment focus
91: Sangamo Therapeutics Inc. - Overview
92: Sangamo Therapeutics Inc. - Product and service
93: Sangamo Therapeutics Inc. - Key offerings
94: Sangamo Therapeutics Inc. - Key customers
95: Sangamo Therapeutics Inc. - Segment focus
96: Thermo Fisher Scientific Inc. - Overview
97: Thermo Fisher Scientific Inc. - Business segments
98: Thermo Fisher Scientific Inc. - Key offerings
99: Thermo Fisher Scientific Inc. - Key customers
100: Thermo Fisher Scientific Inc. - Segment focus
101: Currency conversion rates for US$
102: Research Methodology
103: Validation techniques employed for market sizing
104: Information sources
105: List of abbreviations

Executive Summary

This publisher is pleased to announce their new report, Global Genome Engineering Market 2021-2025

The publisher recognizes the following companies as the key players in the global genome engineering market: CRISPR Therapeutics AG, Danaher Corp., GenScript Biotech Corp., Hera Biolabs Inc., Illumina Inc., Intellia Therapeutics Inc., Merck KGaA, PerkinElmer Inc., Sangamo Therapeutics Inc., and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the publisher said 'The latest trend gaining momentum in the market is potential opportunities in orphan diseases and oncology.'The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • CRISPR Therapeutics AG
  • Danaher Corp.
  • GenScript Biotech Corp.
  • Hera Biolabs Inc.
  • Illumina Inc.
  • Intellia Therapeutics Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Sangamo Therapeutics Inc.
  • Thermo Fisher Scientific Inc.